Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Nov 22, 2024
Date Accepted: Jun 13, 2025

The final, peer-reviewed published version of this preprint can be found here:

Engineering Resilient Community Pharmacies for Chronic Care Management: Protocol for the Development of a Medication Safety Map

Chui MA, Berbakov ME, Gilson AM, Stone JA, Lehnbom EC, Hoffins EL, Moore KG, Ford JH II

Engineering Resilient Community Pharmacies for Chronic Care Management: Protocol for the Development of a Medication Safety Map

JMIR Res Protoc 2025;14:e69011

DOI: 10.2196/69011

PMID: 40934510

PMCID: 12464505

Engineering Resilient Community Pharmacies: A Protocol for Exploring an Integrative Approach to Medication Safety

  • Michelle A Chui; 
  • Maria E Berbakov; 
  • Aaron M Gilson; 
  • Jamie A Stone; 
  • Elin C Lehnbom; 
  • Emily L Hoffins; 
  • Katherine G Moore; 
  • James H Ford II

ABSTRACT

Background:

The increase of people with complex chronic health conditions is stressing the U.S. healthcare delivery system. Community pharmacies play a role in ensuring patients’ safe medication use for chronic care management, but their efforts are undermined by volatile work demands and other system barriers.

Objective:

This study seeks to conceptualize, design, implement, and test a MedSafeMapTM for the community pharmacy setting to enhance pharmacists’ and technicians’ abilities to either avoid, or to quickly identify and recover from, medication errors before patient safety is endangered.

Methods:

Aim 1: Four rounds of observations within the six pharmacy sites will be conducted to parse out areas MedSafeMap could address. Two rounds of interviews with a different one pharmacist and technician from each of the sites will be used to expand upon areas of interest identified during the observations. Aim 2: Focus groups with pharmacists and technicians will aid in the design of MedSafeMap components. Simulation-based research will be utilized to test MedSafeMap components with standardized patients in complex care managament scenarios. Aim 3: MedSafeMap will be implemented into pharmacies. Observations using WOMBAT for time and motion study will aid in understanding how MedSafeMap impacts pharmacy staff workflow.

Results:

As of November 15th, 2024, all six pharmacy sites have been recruited and three of four rounds of observations have been completed. Interviews have been conducted with 12 pharmacists and 11 technicians from the study sites. Preparations for Aim 2 are in the works as Aim 1 analysis continues.

Conclusions:

The MedSafeMap is an innovative approach that will be used by pharmacists and pharmacy technicians to better navigate the complex tasks in the pharmacy, and to facilitate communication with both patients and clinicians, while safely providing medications to complex patients with chronic health conditions.


 Citation

Please cite as:

Chui MA, Berbakov ME, Gilson AM, Stone JA, Lehnbom EC, Hoffins EL, Moore KG, Ford JH II

Engineering Resilient Community Pharmacies for Chronic Care Management: Protocol for the Development of a Medication Safety Map

JMIR Res Protoc 2025;14:e69011

DOI: 10.2196/69011

PMID: 40934510

PMCID: 12464505

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.